Pro Medicus (PME.AX) Azione Prezzo
Pro Medicus Prezzo
Il fatturato è cresciuto a un tasso composto del 17,3% annuo negli ultimi 19 anni, raggiungendo 261,69 Mio. AUD. L'utile per azione è cresciuto del 20,8% all'anno negli ultimi 19 anni. Il margine netto di Pro Medicus si attesta al 101,4%, in aumento rispetto al 47,6% di alcuni anni fa. Pro Medicus offre attualmente un rendimento da dividendo di circa il 0,56%. Il payout ratio è pari a circa il 73% degli utili. Il dividendo è cresciuto del 21,6% all'anno negli ultimi 19 anni. Gli analisti fissano un target di prezzo mediano di 244,80 AUD, ovvero il 53,7% sopra il prezzo attuale. Su 17 analisti, 11 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Pro Medicus Prezzo delle azioni
Pro Medicus Azione e analisi azionaria
Domande frequenti sull'azione Pro Medicus
The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.
Pro Medicus Ltd is primarily active in the healthcare industry.
The main competitors of Pro Medicus Ltd in the market include other medical imaging companies such as Carestream Health, Change Healthcare, and Sectra AB. These companies also specialize in providing medical imaging solutions and technology to healthcare providers and are prominent players in the industry. Pro Medicus Ltd competes with them in terms of product offerings, innovation, customer base, and market share.
Pro Medicus Ltd is a renowned healthcare imaging and information technology provider. Established in 1983, the company has a rich history of pioneering innovative solutions in the medical imaging industry. With a strong focus on radiology, Pro Medicus has developed advanced imaging software that improves efficiency and enhances patient care. The company's success is attributed to its commitment to research and development, resulting in cutting-edge technologies and multiple industry awards. Pro Medicus operates globally, serving prominent healthcare institutions and professionals. With its profound expertise and dedication to advancing medical imaging technology, Pro Medicus Ltd continues to lead the industry in providing innovative solutions for the healthcare sector.
Some significant milestones achieved by Pro Medicus Ltd include the successful expansion into major global markets, such as the United States and Europe, further solidifying its position as a leading provider of healthcare imaging solutions. The company has also experienced continuous revenue growth, achieving record-breaking financial results year after year. Pro Medicus Ltd has consistently developed and released innovative software solutions, enhancing efficiency and productivity for healthcare professionals. Additionally, the company has formed strategic partnerships with top-tier healthcare organizations, further establishing its reputation as a trusted industry leader. These accomplishments have propelled Pro Medicus Ltd's growth and success in the competitive healthcare technology sector.
Pro Medicus Ltd primarily operates in Australia and the United States.
Pro Medicus Ltd is a leading healthcare IT solutions provider with a strong commitment to excellence and innovation. The company's core values revolve around delivering exceptional products and services that empower healthcare professionals to enhance patient care and outcomes. Pro Medicus emphasizes a customer-centric approach and strives to provide customized solutions tailored to meet the unique needs of its clients. With a clear focus on technological advancements and high-quality imaging software, Pro Medicus constantly pushes the boundaries in the healthcare industry. By fostering a culture of collaboration and continuous improvement, Pro Medicus Ltd is dedicated to transforming the way medical images are managed and shared worldwide.
Gli analisti fissano attualmente un prezzo obiettivo medio di 226,59 AUD per l’azione Pro Medicus (mediana: 244,80 AUD), pari a +44,0 % rispetto all’ultimo prezzo. Il consenso si basa su 17 giudizi di analisti.
17 analisti valutano attualmente l’azione Pro Medicus: 13 raccomandano l’acquisto, 4 la tenuta e 0 la vendita.
Convertita al tasso di cambio attuale, l’azione Pro Medicus quota 98,90 EUR (159,25 AUD).
L’azione Pro Medicus (PME.AX) è quotata su 3 borse, tra cui: ASX (PME.AX), Frankfurt (PMC.F).
Pro Medicus Ltd is a global company specializing in providing advanced IT solutions for the healthcare industry. They offer innovative information and image management solutions that are used by leading healthcare organizations worldwide. Their main divisions include Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Telemedicine. Their PACS solutions allow hospitals and healthcare organizations to store, manage, and share digital images from medical diagnostic devices such as CT, MRI, and X-ray machines. These solutions are scalable and provide high-quality image quality for radiologists and other specialists to make informed diagnoses. Their RIS is an integrated solution designed specifically for radiology departments and practices, providing complete patient and order management, as well as integrated workflow tools to improve the efficiency and accuracy of diagnosing and evaluating medical imaging data. Their telemedicine solutions enable radiology professionals to edit and share medical images remotely over the internet, particularly beneficial in facilities with limited resources or for quick access to medical images in emergency diagnoses. In addition, Pro Medicus Ltd also offers specialized solutions for clinical decision support, automated medical image analysis, and patient management. Their clinical decision support provides assistance to medical professionals in diagnosis and treatment monitoring, while the automated analysis of medical image data allows for the quick processing of large amounts of data, producing results that can be utilized by professionals for diagnostic purposes. Their patient management solutions provide comprehensive capture and management of health data that can be used by doctors and other professionals to develop better treatment options for their patients. Pro Medicus Ltd is a global company with a strong focus on research and development. They have partnerships with leading healthcare organizations worldwide and possess a strong portfolio of intellectual property. Their business model is based on the sale of products and services specifically designed for the needs of the healthcare industry. The company emphasizes innovation, customer satisfaction, and delivering high-quality solutions that are scalable and flexible for various users. Overall, Pro Medicus Ltd is an innovative market leader in the field of medical IT solutions. They are globally recognized for their products and services and are expected to continue playing a significant role in the healthcare industry.
Il fatturato di Pro Medicus ammonta a 261,69 Mio. AUD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il profitto di Pro Medicus ammonta a 265,34 Mio. AUD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Pro Medicus è attualmente 62,80. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Pro Medicus.
Il rapporto prezzo/fatturato (P/S) di Pro Medicus è attualmente 63,68. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Pro Medicus.
Il Quality Score AlleAktien per Pro Medicus è 8/10.
L'ISIN di Pro Medicus è AU000000PME8. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Pro Medicus è 591723. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Pro Medicus è PME.AX. Con questo simbolo di borsa vengono negoziate le azioni Pro Medicus in borsa.
Azione Pro Medicus
Gruppo di pari di Pro Medicus
Pro Medicus Ticker
Pro Medicus FIGI
Altre metriche e analisi di Pro Medicus in Deep Dive.
La nostra analisi azionaria dell'azione Pro Medicus include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Pro Medicus. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: